[Recent advances on the thyrocalcitonin].
D000367:Age Factors; D000818:Animals; D001862:Bone Resorption / Q000187:drug effects; D002116:Calcitonin / Q000502:physiology / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D002277:Carcinoma / Q000503:physiopathology; D002417:Cattle; D002418:Cattle Diseases; D006934:Hypercalcemia / Q000188:drug therapy; D006961:Hyperparathyroidism / Q000188:drug therapy; D006996:Hypocalcemia / Q000139:chemically induced / Q000662:veterinary; D007668:Kidney / Q000187:drug effects; D010024:Osteoporosis / Q000188:drug therapy; D010282:Parathyroid Neoplasms / Q000188:drug therapy; D010710:Phosphates / Q000097:blood; D051381:Rats; D011955:Receptors, Drug; D013964:Thyroid Neoplasms / Q000503:physiopathology
D010710:Phosphates; D011955:Receptors, Drug; D002116:Calcitonin; D002118:Calcium
Données récentes sur la thyrocalcitonine.